HC Deb 16 July 1968 vol 768 cc187-8W
54. Mr. Lipton

asked the Minister of Health when KH3 pills were approved for sale without prescription by the Dunlop Committee on Drug Safety; and what steps have been taken by the Medical Research Council to verify the claims made for these pills.

Mr. Snow

I understand that in September, 1966, the Committee advised the promoter that they had no objection, on grounds of safety, to the marketing of KH3. The Medical Research Council have not investigated this treatment.